1. Rigour of development of clinical practice guidelines for the pharmacological treatment of bipolar disorder: Systematic review

    Journal of Affective Disorders 174:45 (2015)

    Background There is an increasing concern about the quality of clinical practice guidelines. Because no information is available on the rigour of development of clinical practice guidelines for bipolar disorder, we carried out a systematic review of those focusing on its phar...
  2. Rigour of development of clinical practice guidelines for the pharmacological treatment of bipolar disorder: systematic review.

    Journal of Affective Disorders 174:45 (2015) PMID 25484176

    There is an increasing concern about the quality of clinical practice guidelines. Because no information is available on the rigour of development of clinical practice guidelines for bipolar disorder, we carried out a systematic review of those focusing on its pharmacological treatment. We searc...
  3. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis.

    British Journal of Psychiatry 206(2):93 (2015) PMID 25644881

    Pharmacological treatment is widely used for post-traumatic stress disorder (PTSD) despite questions over its efficacy. To determine the efficacy of all types of pharmacotherapy, as monotherapy, in reducing symptoms of PTSD, and to assess acceptability. A systematic review and meta-analysis of r...
  4. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis.

    British Journal of Psychiatry 206(2):93 (2015) PMID 25644881

    Pharmacological treatment is widely used for post-traumatic stress disorder (PTSD) despite questions over its efficacy. To determine the efficacy of all types of pharmacotherapy, as monotherapy, in reducing symptoms of PTSD, and to assess acceptability. A systematic review and meta-analysis of r...
  5. When important steps for a reliable meta-analysis are missing: the bevacizumab versus ranibizumab case.

    International journal of ophthalmology 8(1):204 (2015) PMID 25709933

  6. When important steps for a reliable meta-analysis are missing: the bevacizumab versus ranibizumab case.

    International journal of ophthalmology 8(1):204 (2015) PMID 25709933 PMCID PMC4325267

  7. World Health Organization Guidelines for Management of Acute Stress, PTSD, and Bereavement: Key Challenges on the Road Ahead.

    PLOS Medicine 11(12):e1001769 (2014) PMID 25514024 PMCID PMC4267806

    Wietse Tol and colleagues discuss some of the key challenges for implementation of new WHO guidelines for stress-related mental health disorders in low- and middle-income countries. Please see later in the article for the Editors' Summary.
  8. World Health organization guidelines for management of acute stress, PTSD, and bereavement: key challenges on the road ahead.

    PLOS Medicine 11(12):e1001769 (2014) PMID 25514024 PMCID PMC4267806

    Wietse Tol and colleagues discuss some of the key challenges for implementation of new WHO guidelines for stress-related mental health disorders in low- and middle-income countries. Please see later in the article for the Editors' Summary.
  9. World Health Organization Guidelines for Management of Acute Stress, PTSD, and Bereavement: Key Challenges on the Road Ahead.

    PLOS Medicine 11(12):e1001769 (2014) PMID 25514024 PMCID PMC4267806

    Wietse Tol and colleagues discuss some of the key challenges for implementation of new WHO guidelines for stress-related mental health disorders in low- and middle-income countries. Please see later in the article for the Editors' Summary.
  10. World Health Organization Guidelines for Management of Acute Stress, PTSD, and Bereavement: Key Challenges on the Road Ahead.

    PLOS Medicine 11(12):e1001769 (2014) PMID 25514024

    Wietse Tol and colleagues discuss some of the key challenges for implementation of new WHO guidelines for stress-related mental health disorders in low- and middle-income countries. Please see later in the article for the Editors' Summary.
  11. Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure.

    Evidence-Based Mental Health 17(3):69 (2014) PMID 24938274

  12. Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure.

    Evidence-Based Mental Health 17(3):69 (2014) PMID 24938274

  13. Implementation of treatment guidelines for specialist mental health care.

    Schizophrenia Bulletin 40(4):737 (2014) PMID 24837626 PMCID PMC4059448

    Although treatment guidelines are commonly employed in healthcare settings, it remains unclear whether their use has any positive impact on the performance of mental health services or whether they improve patient outcomes. This systematic review is based on a search carried out in March 2012 an...
  14. Implementation of treatment guidelines for specialist mental health care.

    Schizophrenia Bulletin 40(4):737 (2014) PMID 24837626 PMCID PMC4059448

    Although treatment guidelines are commonly employed in healthcare settings, it remains unclear whether their use has any positive impact on the performance of mental health services or whether they improve patient outcomes. This systematic review is based on a search carried out in March 2012 an...
  15. Implementation of treatment guidelines for specialist mental health care.

    Schizophrenia Bulletin 40(4):737 (2014) PMID 24837626 PMCID PMC4059448

    Although treatment guidelines are commonly employed in healthcare settings, it remains unclear whether their use has any positive impact on the performance of mental health services or whether they improve patient outcomes. This systematic review is based on a search carried out in March 2012 an...
  16. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.

    Schizophrenia Research 152(2-3):344 (2014) PMID 24369987

    Similarly to subjects with degenerative parkinsonism, (123)I-FP-CIT SPECT has been reported either normal or abnormal in patients with drug-induced parkinsonism (DIP), challenging the notion that parkinsonism might be entirely due to post-synaptic D2-receptors blockade by antipsychotic drugs. In...
  17. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.

    Schizophrenia Research 152(2-3):344 (2014) PMID 24369987

    Similarly to subjects with degenerative parkinsonism, (123)I-FP-CIT SPECT has been reported either normal or abnormal in patients with drug-induced parkinsonism (DIP), challenging the notion that parkinsonism might be entirely due to post-synaptic D2-receptors blockade by antipsychotic drugs. In...
  18. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study

    Schizophrenia Research 152(2-3):344 (2014)

    Similarly to subjects with degenerative parkinsonism, 123I-FP-CIT SPECT has been reported either normal or abnormal in patients with drug-induced parkinsonism (DIP), challenging the notion that parkinsonism might be entirely due to post-synaptic D2-receptors blockade by antipsychotic d...
  19. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.

    Drug Safety 37(2):79 (2014) PMID 24403009

    Venous thromboembolism (VTE) is a serious disorder that may be complicated by pulmonary embolism (PE). Case reports and observational studies published in the early 1950s suggested that antipsychotic (AP) drugs may represent a risk factor, while observational studies conducted in the last 3 deca...
  20. Decisions on WHO's essential medicines need more scrutiny.

    British Medical Journal (Abstracts) 349:g4798 (2014) PMID 25081250